Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Moodys
McKesson
Johnson and Johnson
Express Scripts

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent Applications for VENLAFAXINE HYDROCHLORIDE


Email this page to a colleague

« Back to Dashboard

US Patent Applications for VENLAFAXINE HYDROCHLORIDE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Try it Free ⤷  Try it Free FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES 2000-12-05 Patented Case 2003-05-21
⤷  Try it Free ⤷  Try it Free Use of sulfamate derivatives for treating impulse control disorders 2000-02-18 Patented Case 2001-11-09
⤷  Try it Free ⤷  Try it Free METHODS AND TRANSDERMAL COMPOSITIONS FOR PAIN RELIEF 2001-01-03 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-07-04
⤷  Try it Free ⤷  Try it Free METHODS FOR TREATING OR PREVENTING FIBROMYALGIA USING VERY LOW DOSES OF CYCLOBENZAPRINE 2001-06-27 Patented Case 2003-03-12
⤷  Try it Free ⤷  Try it Free OSMOTIC DEVICE CONTAINING VENLAFAXINE AND AN ANTI-PSYCHOTIC AGENT 2000-11-30 Patented Case 2003-05-14
⤷  Try it Free ⤷  Try it Free THYROID RECEPTOR LIGANDS 2001-04-17 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-10-17
⤷  Try it Free ⤷  Try it Free MALONAMIC ACIDS AND DERIVATIVES THEREOF AS THYROID RECEPTOR LIGANDS 2001-03-28 Patented Case 2003-11-25
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for VENLAFAXINE HYDROCHLORIDE

WIPO Patent Application Title Patent Filing Date
⤷  Try it Free
⤷  Try it Free
⤷  Try it Free
⤷  Try it Free
⤷  Try it Free
⤷  Try it Free
⤷  Try it Free
>WIPO Patent Application >Title >Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Colorcon
Medtronic
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.